Department: Hematology and Oncology


Molecular/COVID Lab Closes After Four Years of Service in the Face of Unprecedented Pandemic

|

The world shut down in response to COVID-19 in early March 2020. By late March, the University of Tennessee Health Science Center announced it was partnering with University Clinical Health (UCH) to open a lab on the Memphis campus to analyze the deluge of COVID-19 tests being done around town. By May 4, the Molecular/COVID… Read More


UTHSC-Led Team Receives $5.2 Million for Study of Link Between Obesity, Cancer

|

The National Cancer Institute has awarded more than $5.2 million to a team lead by researchers from the University of Tennessee Health Science Center (UTHSC) for a study that will fill critical gaps in knowledge around obesity-mediated cancer risk. Liza Makowski, PhD, professor in the Division of Hematology and Oncology in the UTHSC College of… Read More


Aplastic Anemia & MDS International Foundation (AAMDSIF) Brings its Patient and Family Conference to UTHSC

|

The University of Tennessee Health Science Center is partnering with the Aplastic Anemia & MDS International Foundation (AAMDSIF), along with St. Jude Children’s Research Hospital, Regional One Health, and Baptist Memorial Hospital, to hold the AAMDSIF Patient and Family Conference for the first time in Memphis on July 23. AAMDSIF is a patient-focused non-profit organization… Read More


UTHSC Team Receives $2 Million For Breast Cancer Genetics Research

|

A University of Tennessee Health Science Center team has received $2.05 million from the National Cancer Institute for an advanced genetics project that could help develop targeted therapies and personalized treatment for breast cancer. Liza Makowski, PhD, professor of Hematology and Oncology in the College of Medicine, is the lead investigator on the award. Developing… Read More


UTHSC Physician, Researcher Invited to Present Cancer Research at Prestigious Annual Meeting

|

For two decades, scientists have been able to identify the molecular signature of specific cancers by isolating the RNA, responsible for dictating which proteins are produced and, by extension, how the cells behave in the body. Now, Neil Hayes, MD, MS, MPH, director of the Center for Cancer Research at at the University of Tennessee… Read More